|
EXOSC6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.981900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.782000E-03 |
| Normal-vs-Stage2 |
5.900600E-03 |
| Normal-vs-Stage3 |
6.642200E-01 |
| Normal-vs-Stage4 |
4.268300E-02 |
| Stage1-vs-Stage2 |
4.757800E-01 |
| Stage1-vs-Stage3 |
1.420700E-03 |
| Stage1-vs-Stage4 |
7.937000E-01 |
| Stage2-vs-Stage3 |
9.581400E-03 |
| Stage2-vs-Stage4 |
8.189400E-01 |
| Stage3-vs-Stage4 |
6.321600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.756000E-02 |
| Normal-vs-AfricanAmerican |
2.65020000000948E-06 |
| Normal-vs-Asian |
9.422200E-01 |
| Caucasian-vs-AfricanAmerican |
3.575200E-04 |
| Caucasian-vs-Asian |
4.041400E-01 |
| AfricanAmerican-vs-Asian |
2.383600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.082200E-03 |
| Normal-vs-Female |
9.921900E-02 |
| Male-vs-Female |
1.299410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.592190E-02 |
| Normal-vs-Extreme_Weight |
1.178320E-02 |
| Normal-vs-Obese |
3.068300E-02 |
| Normal-vs-Extreme_Obese |
5.882100E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.191400E-01 |
| Normal_Weight-vs-Obese |
5.585800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.683800E-01 |
| Extreme_Weight-vs-Obese |
8.590800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.270600E-01 |
| Obese-vs-Extreme_Obese |
6.859400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.478200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.568500E-02 |
| Normal-vs-Age(61-80Yrs) |
5.619600E-03 |
| Normal-vs-Age(81-100Yrs) |
5.621700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.984800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.352000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.733770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.160200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.400600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.417400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.138700E-03 |
| Normal-VS-Type2 PRCC |
6.032300E-02 |
| Normal-VS-KIRP CIMP |
4.830200E-01 |
| Normal-VS-Unclassified PRCC |
7.527600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.010200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.899750E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.972200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.226000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.079200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.606200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.466100E-02 |
| Normal-vs-N1 |
9.953600E-01 |
| Normal-vs-N2 |
2.364000E-02 |
| N0-vs-N1 |
7.489900E-02 |
| N0-vs-N2 |
3.447600E-01 |
| N1-vs-N2 |
7.300300E-02 |
|
|
